Ziopharm Oncology to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020
July 28 2020 - 9:00AM
Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced the Company
will host a conference call and webcast on Thursday, August 6, at
4:30 pm EDT to provide a corporate update and discuss financial
results for the second quarter ended June 30, 2020.
The call can be accessed by dialing
1-877-451-6152 (U.S. and Canada) or 1-201-389-0879 (international).
The passcode for the conference call is 13706729. To access the
live webcast or the subsequent archived recording, visit the
“Investors” section of the Ziopharm website at www.ziopharm.com.
The webcast will be recorded and available for replay on the
Company’s website for two weeks.
About Ziopharm Oncology, Inc.
Ziopharm Oncology is an immuno-oncology company focused on
developing end-to-end cost-effective solutions using its non-viral
Sleeping Beauty platform for T-cell receptor (TCR) and chimeric
antigen receptor (CAR) T-cell therapies and immune-stimulating gene
therapy with Controlled interleukin 12 (IL-12). The Sleeping Beauty
platform genetically modifies T cells with DNA plasmids to express
TCRs to target neoantigens inside and outside hotspots for solid
tumors and CAR to target CD19 for blood cancers using the Company’s
“Rapid Personalized Manufacturing” to produce and release CAR-T as
soon as the day after gene transfer. The Sleeping Beauty platform
is being advanced in collaboration with the National Cancer
Institute, The University of Texas MD Anderson Cancer Center and
Eden BioCell. The Company is also developing its Controlled IL-12
platform, or Ad-RTS-hIL-12 plus veledimex, as monotherapy and in
combination with immune checkpoint inhibitors to treat brain
cancer, including in collaboration with Regeneron
Pharmaceuticals.
Ziopharm Oncology Contact: Chris Taylor VP,
Investor Relations and Corporate Communications T: 617.502.1881 E:
ctaylor@ziopharm.com
ZIOPHARM Oncology (NASDAQ:ZIOP)
Historical Stock Chart
From Mar 2024 to Apr 2024
ZIOPHARM Oncology (NASDAQ:ZIOP)
Historical Stock Chart
From Apr 2023 to Apr 2024